Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

The international normalized ratio range of 2.0 to 3.0 remains appropriate for atrial fibrillation.

Singer DE, Fang MC, Go AS.

Arch Intern Med. 2009 Nov 23;169(21):2032; author reply 2033. doi: 10.1001/archinternmed.2009.419. No abstract available.

PMID:
19933969
2.
3.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Selçuk H, Selçuk MT, Maden O.

Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8. Review. Turkish.

4.

The need for new oral anticoagulants in clinical practice.

Hylek EM.

J Cardiovasc Med (Hagerstown). 2009 Aug;10(8):605-9. doi: 10.2459/JCM.0b013e32832e4954. Review.

PMID:
19571764
5.

New oral anticoagulants in atrial fibrillation.

Turpie AG.

Eur Heart J. 2008 Jan;29(2):155-65. Epub 2007 Dec 19. Review.

6.

[Thromboembolism in non-rheumatic atrial fibrillation].

Pengo V.

Haematologica. 2001 Sep;86(9 Suppl):5-11. Review. Italian. No abstract available.

PMID:
11759619
7.

Oral anticoagulant therapy for patients with atrial fibrillation--an update.

Hylek EM.

Thromb Res. 2008;123 Suppl 1:S46-9. doi: 10.1016/j.thromres.2008.08.016. Epub 2008 Sep 21. Review. No abstract available.

PMID:
18809205
8.

Anticoagulation in atrial fibrillation and flutter.

Scholten MF, Thornton AS, Mekel JM, Koudstaal PJ, Jordaens LJ.

Europace. 2005 Sep;7(5):492-9. Review.

9.

Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory properties.

Palagummi P, Saltzman H, Ezekowitz M.

Am Heart J. 2005 Jan;149(1 Suppl):S32-5. Review. No abstract available.

PMID:
15644791
10.

[Anticoagulation in atrial fibrillation].

Binggeli C, Brunckhorst CB.

Herz. 2008 Feb;33(1):13-9. doi: 10.1007/s00059-008-3090-8. Review. German.

PMID:
18273573
11.

[Stroke and atrial fibrillation].

Gahn G.

Herzschrittmacherther Elektrophysiol. 2009 Jun;20(2):70-2. doi: 10.1007/s00399-009-0045-6. Review. German.

PMID:
19484179
12.

[Atrial fibrillation: novel possibilities of anticoagulant therapy in patients subjected to cardioversion].

Averkov OV.

Kardiologiia. 2011;51(7):53-7. Review. Russian. No abstract available.

PMID:
21878086
13.

Ablation for atrial fibrillation: can we decrease thromboembolism without increasing the risk for bleeding?

Asirvatham SJ.

Circulation. 2007 Nov 27;116(22):2517-9. Review. No abstract available.

14.

Reducing the risk for stroke in patients who have atrial fibrillation.

Garcia DA, Hylek E.

Cardiol Clin. 2008 May;26(2):267-75, vii. doi: 10.1016/j.ccl.2007.12.011. Review.

PMID:
18406999
15.

Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.

Martí-Fàbregas J, Mateo J.

Cerebrovasc Dis. 2009;27 Suppl 1:111-9. doi: 10.1159/000200448. Epub 2009 Apr 3. Review.

PMID:
19342840
16.

[Low-intensity anticoagulant treatment--indications and efficacy].

Frenkel Rubin M, Skurnik Y, Sthoeger Z.

Harefuah. 1999 May 2;136(9):708-12. Review. Hebrew. No abstract available.

PMID:
10955095
17.

[Prevention of brain infarction in patients with atrial fibrillation].

Ogata T, Yasaka M.

Brain Nerve. 2007 Jan;59(1):53-8. Review. Japanese.

PMID:
17354379
18.

[Prevention of brain infarction in patients with atrial fibrillation].

Ogata T, Yasaka M.

No To Shinkei. 2007 Jan;59(1):53-8. Review. Japanese.

PMID:
17228779
19.

Does dabigatran interfere with intraablation heparinization?

Sairaku A, Nakano Y, Kihara Y.

Thromb Res. 2014 Sep;134(3):742-3. doi: 10.1016/j.thromres.2014.06.026. Epub 2014 Jul 5. Review. No abstract available.

PMID:
25034323
20.

Atrial fibrillation: management for the geriatric patient.

Krishnan K.

Am J Geriatr Cardiol. 2005 Sep-Oct;14(5):242-7; quiz 248-9. Review.

PMID:
16247283
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk